BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

851 related articles for article (PubMed ID: 6136027)

  • 1. Drug therapy of inflammatory bowel disease.
    Sack DM; Peppercorn MA
    Pharmacotherapy; 1983; 3(3):158-76. PubMed ID: 6136027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current status of drug therapy for inflammatory bowel disease.
    Peppercorn MA
    Compr Ther; 1985 Dec; 11(12):14-9. PubMed ID: 2866866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-benefit assessment of drugs used in the treatment of inflammatory bowel disease.
    Hanauer SB; Stathopoulos G
    Drug Saf; 1991; 6(3):192-219. PubMed ID: 1676590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maintenance therapy in ulcerative colitis and Crohn's disease.
    Sachar DB
    J Clin Gastroenterol; 1995 Mar; 20(2):117-22. PubMed ID: 7769190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Local or systemic treatment of inflammatory bowel diseases?].
    Schmassmann A; Halter F
    Ther Umsch; 1993 Feb; 50(2):94-9. PubMed ID: 8096092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical guide to the management of distal ulcerative colitis.
    Ardizzone S; Bianchi Porro G
    Drugs; 1998 Apr; 55(4):519-42. PubMed ID: 9561342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medical management of severe inflammatory disease of the rectum and distal colon: non-nutritional aspects.
    Polson RJ; Misiewicz JJ
    Baillieres Clin Gastroenterol; 1992 Mar; 6(1):1-26. PubMed ID: 1586763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of 6-mercaptopurine in the treatment of inflammatory bowel disease].
    Hinojosa J; Molés JR; Nos P; Hoyos M; Ramírez JJ; Primo J; Fernández J; Berenguer J
    Rev Esp Enferm Dig; 1995 Nov; 87(11):775-80. PubMed ID: 8534531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical treatment of inflammatory bowel disease: new therapies, new drugs.
    Sutherland LR
    CMAJ; 1987 Nov; 137(9):799-802. PubMed ID: 2894889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug treatment of inflammatory bowel disease.
    Lennard-Jones JE; Powell-Tuck J
    Clin Gastroenterol; 1979 Jan; 8(1):187-217. PubMed ID: 33775
    [No Abstract]   [Full Text] [Related]  

  • 12. How important is onset of action in ulcerative colitis therapy?
    Masson S; Nylander D; Mansfield JC
    Drugs; 2005; 65(15):2069-83. PubMed ID: 16225364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfasalazine. Pharmacology, clinical use, toxicity, and related new drug development.
    Peppercorn MA
    Ann Intern Med; 1984 Sep; 101(3):377-86. PubMed ID: 6147110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy of inflammatory bowel disease. Part 1. Sulfasalazine.
    Das KM
    Postgrad Med; 1983 Dec; 74(6):141-8, 150-1. PubMed ID: 6139795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medical therapy for ulcerative colitis in childhood.
    Ament ME; Vargas JH
    Semin Pediatr Surg; 1994 Feb; 3(1):28-32. PubMed ID: 7914811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical management of patients with difficult-to-treat inflammatory bowel disease.
    van Hogezand RA
    Neth J Med; 1994 Aug; 45(2):55-9. PubMed ID: 7936006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug therapy of chronic inflammatory bowel disease--reliable standards and new developments].
    Fischbach W
    Leber Magen Darm; 1992 Mar; 22(2):49-55. PubMed ID: 1350043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative therapy of ulcerative colitis and Crohn disease].
    Rasenack J; Kreisel W
    Fortschr Med; 1991 Apr; 109(11):245-7. PubMed ID: 1855750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug management of inflammatory bowel disease.
    McCarthy CF
    Ir Med J; 1983 May; 76(5):260-2. PubMed ID: 6135675
    [No Abstract]   [Full Text] [Related]  

  • 20. Newer pharmacologic agents for the therapy of inflammatory bowel disease.
    Ruderman WB
    Med Clin North Am; 1990 Jan; 74(1):133-53. PubMed ID: 2404172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.